India's Intranasal Covid Vaccine Is Here. Can Be Availed On COWIN Platform

Covid Intranasal Vaccine: The needle-free vaccine will be available at private hospitals as of now.

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform this evening, official sources told Press Trust of India.

The needle-free vaccine will be available at private hospitals as of now.

It is likely to be rolled out in the national Covid vaccination programme soon, sources told Press Trust of India.

The ministry's approval for the intranasal vaccine comes amid a spurt in Covid cases in China and some other countries.